Having trouble viewing this email? View the online version. Unsubscribe.
SexHealthMatters logo
email-top-stripe
Women With MS at Higher Risk for Sexual Dysfunction

Almost two-thirds of people with multiple sclerosis (MS) have sexual problems. What might women wtih MS expect? A recent Journal of Sexual Medicine study considered that question.

Researchers analyzed information for almost 1,500 women. Just over half of the participants had MS. 

The research team discovered that women with MS had almost twice the risk of sexual dysfunction compared to women without MS. Difficulties with desire, vaginal lubrication, orgasm, and pain were some of the most common issues.

Click here to learn more about the study, including the physical and psychological ways MS interferes with sex, and steps couples can take to adapt. 

Sexual Enhancement Products Might Contain Hidden Ingredients

Experts warn that some dietary supplements, including some marketed as sexual enhancement products, contain hidden ingredients that could be harmful. 

Researchers analyzed ten years of data from the U.S. Food and Drug Administration (FDA)'s Tainted Supplements database. Such supplements contain ingredients that are not approved by the FDA, and product labels do not always list them.

In a group of 776 supplements, almost 46% were intended for sexual enhancement. The majority of these contained sildenafil or a similar compound. Sildenafil is the active ingredient in Viagra, a prescription drug used to treat erectile dysfunction (ED).

Find out why experts are so concerned. 

In the News...

Drug Might Preserve Ovarian Function in Some Breast Cancer Patients

New research suggests that injections of a drug called goserelin, in addition to standard chemotherapy, could lower the risk of ovarian failure in women with hormone-receptor negative breast cancer.

Chemotherapy can damage the ovaries. When this happens, women's bodies produce much less estrogen (an important female sex hormone), triggering early menopause. 

Learn more.

Fewer Sexual Side Effects Found with Antidepressant Trintellix

The U.S. Food and Drug Administration (FDA) has approved new labelling for the antidepressant Trintellix (vortioxetine), noting that the drug may have fewer sexual side effects than other antidepressants. 

Researchers conducted an 8-week trial involving 447 patients with major depressive disorder who were experiencing sexual side effects from their medication.  Some of the patients took Trintellix; the rest took another antidepressant called escitalopram. 

When the researchers compared the two groups at the study's close, they found that patients who took Trintellix had greater improvements in sexual function.

Get the details here. 

Happy Holidays!

We wish all of our readers a happy and healthy holiday season with best wishes for the new year! 

You are receiving this newsletter because you are subscribed to our mailing list.
If you would rather not receive emails like this in the future you can unsubscribe.

Sexhealthmatters.org | Sexual Medicine Society of North America, Inc.
14305 Southcross Drive, Suite 100, Burnsville, MN 55306

healthcommunities.com